Earnings Alerts

Bath & Body Works (BBWI) Earnings: FY Sales Forecast Stable with 1%-3% Growth and EPS Projections Strong

  • Bath & Body Works maintains its full-year sales forecast, expecting an increase of 1% to 3%.
  • The company also keeps its full-year earnings per share (EPS) forecast, ranging from $3.25 to $3.60.
  • For the first quarter, Bath & Body Works forecasts EPS between 36 cents and 43 cents.
  • The first-quarter sales expectation also aligns with a 1% to 3% increase.
  • Analysts’ recommendations include 15 buys, 5 holds, and no sell ratings.

A look at Bath & Body Works Smart Scores

FactorScoreMagnitude
Value0
Dividend3
Growth4
Resilience5
Momentum5
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Bath & Body Works seems to have a promising long-term outlook. With strong scores in Growth, Resilience, and Momentum, the company is positioned well for future success. The Growth score of 4 suggests that Bath & Body Works is expected to expand and increase its market presence over time. Additionally, its high Resilience and Momentum scores of 5 indicate that the company is well-equipped to weather challenges and has positive market momentum going forward. Although the Value score is lower at 0, the overall outlook for Bath & Body Works appears positive based on these key factors.

Bath & Body Works, Inc. is a company that specializes in manufacturing personal care products including fragrances, gifts, body care, and bath products. With a global customer base, the company caters to a wide audience seeking high-quality personal care items. The company’s strong emphasis on Growth, Resilience, and Momentum according to the Smartkarma Smart Scores suggests a solid foundation for continued success in the market. Investors may consider Bath & Body Works as a potential long-term investment opportunity based on its positive outlook and strategic positioning in the personal care products industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars